Optina Diagnostics Inc.: Clinical Trials

11 trials sponsored by Optina Diagnostics Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 2 withdrawn, 1 recruiting. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Withdrawn 1

Follow Optina Diagnostics Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The GA in HSI Study
Retrospective Study - Geographic Atrophy, Healthy
CompletedOptina Diagnostics Inc.422024-12-242025-03-06
Retinal Deep Phenotyping.TM
Healthy
WithdrawnOptina Diagnostics Inc.2023-11-302024-01-25
RDP Reliability Study
Retinal Imaging with Optina4C Camera - Healthy
CompletedOptina Diagnostics Inc.432023-09-192024-02-29
Retinal Deep PhenotypingTM
Healthy
CompletedOptina Diagnostics Inc.8132023-04-032024-12-13
Hyperspectral Drusen Classification
Mydriatic Hyperspectral retinal Camera, (MHRC) and Optical coherence tomography (OCT) - Dry Age Related Macular Degeneration
CompletedOptina Diagnostics Inc.1122022-11-082025-03-06
Optina Eye to Heart Connection
Coronary Artery Disease
CompletedOptina Diagnostics Inc.3082022-06-152024-05-23
Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test
Alzheimer Disease, Mild Cognitive Impairment
CompletedOptina Diagnostics Inc.4662022-06-072024-08-07
Eye to Brain Connection
Alzheimer Disease
CompletedOptina Diagnostics Inc.652022-03-142023-03-24
Contribution of the Kinematic Theory in the Early Differential Diagnosis of the Parkinson's Disease
Parkinson Disease, Healthy
RecruitingCentre hospitalier de l'Université de Montréal (CHUM)902020-02-192025-02-14
Retinal Metabolic Imaging of Alzheimer Patient
MHRC - Alzheimer Disease
Not applicableCompletedOptina Diagnostics Inc.492017-12-042023-03-28
Retinal Metabolic Imaging in a Diverse Population
MHRC Camera - Technical Capabilities of the Device
Not applicableWithdrawnOptina Diagnostics Inc.2017-07-052023-03-28

Conditions studied

Alzheimer Disease (3)  ·  Cognitive Dysfunction (1)  ·  Coronary Artery Disease (1)  ·  Geographic Atrophy (1)  ·  Parkinson Disease (1)  ·  Parkinsonian Disorders (1)

Interventions

Retrospective Studies (1)  ·  Tomography, Optical Coherence (1)

Countries

Canada (9)  ·  United States (3)

Top investigators

Sandra Black, MD (2)  ·  Charles Bernick, MD, MPH (1)  ·  Dr. Jean Daniel Arbour, MD, FRCSC (1)  ·  Giovanni J Marotta, MD, FRCP(C) (1)  ·  Hamid Okhravi, MD, PhD FRPC (1)  ·  Jean-Claude Tardiff (1)  ·  Jorge P. Bruno, MD (1)  ·  Peter Kertes, MD (1)  ·  Pierre Blanchet (1)  ·  Ramina Nissan, O.D (1)  ·  Ramina Nissan, OD (1)  ·  Richard Bergeron, PhD FRPC (1)  ·  Suman Jayadev, MD (1)